Could the 185delAG BRCA1 mutation be an ancient Jewish mutation?
- PMID: 9450187
Could the 185delAG BRCA1 mutation be an ancient Jewish mutation?
Abstract
A predominant mutation within the BRCA1 predisposition gene, 185delAG, has been detected in about 1% of the Ashkenazi population, considered a high-risk group for breast and ovarian cancers. We examined 639 unrelated healthy Jews of Iraqi extraction, a presumed low-risk group, for the existence of this mutation. Three individuals were identified as 185delAG mutation carriers, and haplotype analysis of the Iraqi mutation carriers revealed that 2 of the Iraqis shared a common haplotype with 6 Ashkenazi mutation carriers, and 1 had a haplotype which differed by a single marker. This study suggests that the BRCA1 185delAG mutation also occurs in populations considered at low-risk for breast and ovarian cancers, and that it might have occurred prior to the dispersion of the Jewish people in the Diaspora, at least at the time of Christ.
Similar articles
-
The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.Br J Cancer. 2000 Aug;83(4):463-6. doi: 10.1054/bjoc.2000.1249. Br J Cancer. 2000. PMID: 10945492 Free PMC article.
-
Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.Hum Mutat. 2000 Dec;16(6):491-501. doi: 10.1002/1098-1004(200012)16:6<491::AID-HUMU6>3.0.CO;2-J. Hum Mutat. 2000. PMID: 11102978
-
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):467-73. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11352856
-
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.Clin Cancer Res. 2002 Dec;8(12):3776-81. Clin Cancer Res. 2002. PMID: 12473589
-
Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients.Gynecol Oncol. 2000 Aug;78(2):148-51. doi: 10.1006/gyno.2000.5848. Gynecol Oncol. 2000. PMID: 10926794
Cited by
-
Cancer in Jews: introduction and overview.Fam Cancer. 2004;3(3-4):177-92. doi: 10.1007/s10689-004-9538-y. Fam Cancer. 2004. PMID: 15516840 Review.
-
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.Am J Hum Genet. 1998 Jun;62(6):1381-8. doi: 10.1086/301885. Am J Hum Genet. 1998. PMID: 9585613 Free PMC article.
-
The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews.Fam Cancer. 2005;4(2):85-8. doi: 10.1007/s10689-004-2101-z. Fam Cancer. 2005. PMID: 15951957
-
Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing.Fam Cancer. 2006;5(4):327-35. doi: 10.1007/s10689-006-0002-z. Epub 2006 May 25. Fam Cancer. 2006. PMID: 16724248
-
Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries.Neurogenetics. 2009 Oct;10(4):355-8. doi: 10.1007/s10048-009-0186-0. Epub 2009 Mar 13. Neurogenetics. 2009. PMID: 19283415
MeSH terms
Substances
LinkOut - more resources
Miscellaneous